Tim Fugmann

发表

Regulation of secretory transport by protein kinase D–mediated phosphorylation of the ceramide transfer protein

K. Pfizenmaier, M. Olayioye, Tim Fugmann, 2007, The Journal of cell biology.

BST-2 as a target for antibody-based therapy In vivo biotinylation of the vasculature in B-cell lymphoma identifies

H. Kamada, D. Neri, Tim Fugmann, 2013 .

Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.

D. Neri, Tim Fugmann, C. Roesli, 2010, Journal of proteomics.

In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.

W. Klapper, H. Kamada, D. Neri, 2010, Blood.

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer

E. Eyras, J. Yokota, F. Sanz, 2020, bioRxiv.

The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis

F. Bootz, D. Ritz, D. Neri, 2017, The Journal of Immunology.

Data‐Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform

D. Ritz, D. Neri, Tim Fugmann, 2017, Proteomics.

DeepQuanTR: MALDI‐MS‐based label‐free quantification of proteins in complex biological samples

D. Neri, Tim Fugmann, C. Roesli, 2010, Proteomics.

This information is current as Induced Colitis Lymph Nodes in Health and in Chemically The MHC Class II Immunopeptidome of Bootz and

F. Bootz, D. Ritz, D. Neri, 2016 .

Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA

G. Schneider, S. Wessler, B. Hoy, 2016, Scientific Reports.

Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice

D. Neri, Tim Fugmann, Theo Sturm, 2019, Molecular Cancer Therapeutics.

From target discovery to clinical trials with armed antibody products.

D. Neri, Tim Fugmann, G. Elia, 2014, Journal of proteomics.

Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy.

C. Forsblom, P. Hamar, D. Neri, 2011, Kidney international.

High‐sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera

Dario Neri, Claus Garbe, Tim Fugmann, 2016, Proteomics.

Membranal and Blood‐Soluble HLA Class II Peptidome Analyses Using Data‐Dependent and Independent Acquisition

D. Neri, Tim Fugmann, H. Debiec, 2018, Proteomics.

Intron retention as a novel source of cancer neoantigens

E. V. Van Allen, Kwok-Kin Wong, Harold Pimentel, 2018, bioRxiv.

Intron retention is a source of neoepitopes in cancer

Kwok-Kin Wong, Harold Pimentel, Meng Xiao He, 2018, Nature Biotechnology.

Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes

Dario Neri, Tim Fugmann, D. Neri, 2016, Cancer Immunology, Immunotherapy.

Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.

A. Oxenius, M. Colombo, D. Neri, 2017, Cancer research.

High‐resolution analysis of the murine MHC class II immunopeptidome

Dario Neri, Tim Fugmann, D. Neri, 2016, European journal of immunology.

Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery

D. Neri, Tim Fugmann, Andreas Gloger, 2017, Proteomics.

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

I. Svane, A. Bentzen, S. Hadrup, 2019, Oncoimmunology.

A proteomic approach for the identification of vascular markers of liver metastasis.

R. Giavazzi, D. Neri, Tim Fugmann, 2010, Cancer research.

Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine

D. Neri, Tim Fugmann, Marco Stringhini, 2018, Clinical Cancer Research.

Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.

P. Kaufmann, D. Neri, Tim Fugmann, 2011, Atherosclerosis.

A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.

M. Manz, D. Neri, Tim Fugmann, 2014, Journal of proteomics.

The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis.

M. Jucker, D. Neri, Tim Fugmann, 2011, Journal of proteomics.

Improved protein sequence coverage by on resin deglycosylation and cysteine modification for biomarker discovery

H. Kamada, D. Neri, Tim Fugmann, 2009, Proteomics.